Your search returned 31 results.

Results
	21.	Activity of X-linked genes in stem and differentiated Mus musculus X Mus caroli hybrid cells. [electronic resource] by Huebner, K Nagarajan, L deJesus, E Orkin, S H Caskey, C T Croce, C M Producer: 19850729 In: Cell differentiation vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	22.	Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model. [electronic resource] by Whitman, M S Pitsakis, P G DeJesus, E Osborne, A J Levison, M E Johnson, C C Producer: 19970129 In: Antimicrobial agents and chemotherapy vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	23.	Melanoma cell lines from different stages of progression and their biological and molecular analyses. [electronic resource] by Satyamoorthy, K DeJesus, E Linnenbach, A J Kraj, B Kornreich, D L Rendle, S Elder, D E Herlyn, M Producer: 19980609 In: Melanoma research vol. 7 Suppl 2 Availability: No items available. Save to lists Add to cart (remove)
	24.	Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir. [electronic resource] by Ross, L L Rouse, E Gerondelis, P DeJesus, E Cohen, C Horton, J Ha, B Lanier, E R Elion, R Producer: 20100317 In: The Journal of antimicrobial chemotherapy vol. 65 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	25.	9 hot technology trends. [electronic resource] by DeJesus, E X Essex, D Manning, J Nussbaum, G M Klein, J Joch, A Cheriyan, A Work, M Pawola, L Producer: 19990422 In: Healthcare informatics : the business magazine for information and communication systems vol. 16 Availability: No items available. Save to lists Add to cart (remove)
	26.	Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial. [electronic resource] by Orkin, C DeJesus, E Khanlou, H Stoehr, A Supparatpinyo, K Lathouwers, E Lefebvre, E Opsomer, M Van de Casteele, T Tomaka, F Producer: 20130419 In: HIV medicine vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	27.	Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. [electronic resource] by Nesbit, M Nesbit, H K Bennett, J Andl, T Hsu, M Y Dejesus, E McBrian, M Gupta, A R Eck, S L Herlyn, M Producer: 20000104 In: Oncogene vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	28.	The ASSURE study: HIV-1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavir. [electronic resource] by Wohl, D A Bhatti, L Small, C B Edelstein, H Zhao, H H Margolis, D A DeJesus, E Weinberg, W G Ross, L L Shaefer, M S Producer: 20161213 In: HIV medicine vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	29.	SWIFT: prospective 48-week study to evaluate efficacy and safety of switching to emtricitabine/tenofovir from lamivudine/abacavir in virologically suppressed HIV-1 infected patients on a boosted protease inhibitor containing antiretroviral regimen. [electronic resource] by Campo, R DeJesus, E Bredeek, U F Henry, K Khanlou, H Logue, K Brinson, C Benson, P Dau, L Wang, H White, K Flaherty, J Fralich, T Guyer, B Piontkowsky, D Producer: 20140319 In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	30.	Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients. [electronic resource] by Vrouenraets, S M E Wit, F W N M Fernandez Garcia, E Moyle, G J Jackson, A G Allavena, C Raffi, F Jayaweera, D T Mauss, S Katlama, C Fisher, M Slama, L Hardy, W D Dejesus, E van Eeden, A Reiss, P Producer: 20120103 In: HIV medicine vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	31.	Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96-week results from two randomized clinical trials. [electronic resource] by Hagins, D Orkin, C Daar, E S Mills, A Brinson, C DeJesus, E Post, F A Morales-Ramirez, J Thompson, M Osiyemi, O Rashbaum, B Stellbrink, H-J Martorell, C Liu, H Liu, Y-P Porter, D Collins, S E SenGupta, D Das, M Producer: 20190619 In: HIV medicine vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)